BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE

By Walenga J.M.   Jeske W.P.   Bara L.   Samama M.M.   Fareed J.  

Thrombosis Research, Vol. 86, Iss. 1, 1997-04 ,pp. : 1-36

Elsevier

Access to resources Recommend Favorite

Antithrombin binding by human umbilical vein endothelial cells: effects of exogenous heparin

By Justus A.C.   Roussev R.   Norcross J.L.   Faulk W.P.  

Thrombosis Research, Vol. 79, Iss. 2, 1995-07 ,pp. : 175-186

Elsevier

Access to resources Recommend Favorite

Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits

By Tazawa S.   Ichikawa K.   Misawa K.   Fukuyama J.   Hamano S.   Miyata H.   Sakuragawa N.  

Thrombosis Research, Vol. 80, Iss. 5, 1995-12 ,pp. : 391-398

Elsevier

Access to resources Recommend Favorite

Interaction of heparin with fibrinogen using surface plasmon resonance technology: investigation of heparin binding site on fibrinogen

By Raut S.   Gaffney P.J.  

Thrombosis Research, Vol. 81, Iss. 4, 1996-02 ,pp. : 503-509

Elsevier

Access to resources Recommend Favorite

Chemical Sulfonation and Anticoagulant Activity of Acharan Sulfate - Antithrombin III-and heparin cofactor II-independent inhibition of factor X activation by factor IXa-Factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin

By Wu S.J.   Chun M.W.   Shin K.H.   Toida T.   Park Y.   Linhardt R.J.   Kim Y.S.  

Thrombosis Research, Vol. 92, Iss. 6, 1998-12 ,pp. : 273-281

Elsevier

Access to resources Recommend Favorite